Ulcerative colitis: current pharmacotherapy and future directions

Review article: strategies for the management of chronic unremitting ulcerative colitis

(2013) S. J. Mehta et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: the role of anti-TNF in the management of ulcerative colitis - past, present and future

(2013) S. Danese et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Risk of Colorectal High-Grade Dysplasia and Cancer in a Prospective Observational Cohort of Patients With Inflammatory Bowel Disease

(2013) Laurent Beaugerie et al.   GASTROENTEROLOGY

Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Methotrexate in Combination With Infliximab Is No More Effective Than Infliximab Alone in Patients With Crohn's Disease

(2013) Brian G. Feagan et al.   GASTROENTEROLOGY

Combination Therapy With Infliximab and Azathioprine Is Superior to Monotherapy With Either Agent in Ulcerative Colitis

(2013) Remo Panaccione et al.   GASTROENTEROLOGY

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

(2013) Simon P L Travis et al.   GUT

P-145 Welcome 54-week Open-label Extension

(2013) Brian Feagan et al.   INFLAMMATORY BOWEL DISEASES

Oral tacrolimus for pediatric steroid-resistant ulcerative colitis

(2013) V.M. Navas-López et al.   Journal of Crohns & Colitis

Colorectal cancer in inflammatory bowel disease: Results of the 3rd ECCO pathogenesis scientific workshop (I)

(2013) Shaji Sebastian et al.   Journal of Crohns & Colitis

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

(2012) W. J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Immunosuppressive and biologic therapy for ulcerative colitis

(2012) Sandro Ardizzone et al.   EXPERT OPINION ON EMERGING DRUGS

Once-Daily Budesonide MMX® Extended-Release Tablets Induce Remission in Patients With Mild to Moderate Ulcerative Colitis: Results From the CORE I Study

(2012) William J. Sandborn et al.   GASTROENTEROLOGY

Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study

(2012) Marte Lie Høivik et al.   GUT

Extracorporeal Photopheresis (ECP) in Patients with Steroid-dependent Crohnʼs Disease

(2012) Walter Reinisch et al.   INFLAMMATORY BOWEL DISEASES

Infliximab versus cyclosporine as rescue therapy in acute severe steroid-refractory ulcerative colitis: a systematic review and meta-analysis

(2012) Kah Hoong Chang et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management

(2012) Axel Dignass et al.   Journal of Crohns & Colitis

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

(2012) David Laharie et al.   LANCET

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

(2012) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease

(2012) Gerda C. Leitner et al.   TRANSFUSION MEDICINE AND HEMOTHERAPY

Randomised clinical trial: delayed-release oral mesalazine 4.8 g/day vs. 2.4 g/day in endoscopic mucosal healing - ASCEND I and II combined analysis

(2011) G. R. Lichtenstein et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

(2011) Sandro Ardizzone et al.   Clinical Gastroenterology and Hepatology

Future Therapeutic Approaches for Inflammatory Bowel Diseases

(2011) Scott E. Plevy et al.   GASTROENTEROLOGY

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

(2011) Jean Frédéric Colombel et al.   GASTROENTEROLOGY

Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial

(2011) W. Reinisch et al.   GUT

Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids

(2011) Míriam Mañosa et al.   INFLAMMATORY BOWEL DISEASES

Ulcerative Colitis as A Progressive Disease: The Forgotten Evidence

(2011) Joana Torres et al.   INFLAMMATORY BOWEL DISEASES

Serum albumin concentration: a predictive factor of infliximab pharmacokinetics and clinical response in patients with ulcerative colitis

(2011) A.A. Fasanmade et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease

(2010) David S. Kotlyar et al.   Clinical Gastroenterology and Hepatology

Management of acute severe ulcerative colitis

(2010) G. Van Assche et al.   GUT

The use of Cyclosporin A in acute steroid-refractory ulcerative colitis: Long term outcomes

(2010) Lisa Sharkey et al.   Journal of Crohns & Colitis

Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: Clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan

(2009) T. Hibi et al.   DIGESTIVE AND LIVER DISEASE

The Impact of Ulcerative Colitis on Patients’ Lives Compared to Other Chronic Diseases: A Patient Survey

(2009) David T. Rubin et al.   DIGESTIVE DISEASES AND SCIENCES

Delayed-Release Oral Mesalamine 4.8 g/day (800-mg Tablet) Is Effective for Patients With Moderately Active Ulcerative Colitis

(2009) William J. Sandborn et al.   GASTROENTEROLOGY

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

(2008) Elana A. Maser et al.   Clinical Gastroenterology and Hepatology

Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study)

(2008) Inger Camilla Solberg et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY